Soleno Therapeutics Announces $15 Million Private Placement
Dec 12, 2017 13:31 pm UTC| Business
Financing to Support Planned Phase III Clinical Program for DCCR in Prader-Willi Syndrome REDWOOD CITY, Calif., Dec. 12, 2017 -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company...
UroGen Pharma Expands Clinical Development Leadership Team
Dec 12, 2017 13:31 pm UTC| Business
Mark Schoenberg, M.D., Named Chief Medical Officer Elyse Seltzer, M.D., Appointed Senior Vice President of Clinical Development RAANANA, Israel and NEW YORK, Dec. 12, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a...
PeerLogix Announces Worldwide Entertainment Rankings for Week Ending December 10th, 2017
Dec 12, 2017 13:31 pm UTC| Business
NEW YORK, NY , Dec. 12, 2017 -- PeerLogix, Inc. (the "Company") (“We”) (OTCQB: LOGX), the established standard for tracking non-subscription based Over-the-Top (“OTT”) engagement data, today announced select...
Dec 12, 2017 13:31 pm UTC| Business
ROCKVILLE, Md., Dec. 12, 2017 -- Hillcrest Labs, a subsidiary of InterDigital, Inc. (NASDAQ:IDCC), today announced the latest expansion of its sensor node product line. The BNO085, a 9-Axis System in Package (SiP),...
Dec 12, 2017 13:31 pm UTC| Business
LEIDEN, Netherlands and MILPITAS, Calif., Dec. 12, 2017 -- IXYS Corporation (NASDAQ:IXYS), a global manufacturer of power semiconductors and integrated circuits (ICs) for energy efficiency, power management,...
Vemanti Group To Make Investment In Blockchain-Focused Energy Trading Company
Dec 12, 2017 13:31 pm UTC| Business
NEWPORT BEACH, Calif., Dec. 12, 2017 -- Vemanti Group, Inc. (OTC PINK:VMNT), a technology-driven holding company, today announced that it has signed a Letter of Intent (LOI) to make an investment in Platinum Energy...
Onconova Presents Data on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2017 Meeting
Dec 12, 2017 13:30 pm UTC| Business
Oral rigosertib as a single agent demonstrates activity in a Phase 2 trial for lower-risk MDS32% of 62 evaluable patients, and 44% of patients receiving optimal dosing, achieved transfusion independenceNew data on the...
CDPB’s Oversight on Digital Payment Services: A Response to Growing Security
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update